{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:52:37Z","timestamp":1740135157830,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia","award":["FRGS\/1\/2016\/SKK09\/UKM\/02\/1"],"award-info":[{"award-number":["FRGS\/1\/2016\/SKK09\/UKM\/02\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2868-9","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T20:48:56Z","timestamp":1512679736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A clinical tool to predict Plasmodium vivax recurrence in Malaysia"],"prefix":"10.1186","volume":"17","author":[{"given":"Norliza","family":"Mat Ariffin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4450-4361","authenticated-orcid":false,"given":"Farida","family":"Islahudin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Endang","family":"Kumolosasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd","family":"Makmor-Bakry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"2868_CR1","unstructured":"World Health Organization. World Malaria Report 2016. Geneva: WHO; 2016."},{"key":"2868_CR2","doi-asserted-by":"publisher","unstructured":"Degefa T, Zeynudin A, Zemene E, Emana D, Yewhalaw D. High prevalence of gametocyte carriage among individuals with asymptomatic malaria: implications for sustaining malaria control and elimination efforts in ethiopia. Hum Parasit Dis. 2016. doi: 10.4137\/HPD.S34377 .","DOI":"10.4137\/HPD.S34377"},{"key":"2868_CR3","first-page":"1","volume":"1","author":"WA Krotoski","year":"1989","unstructured":"Krotoski WA. The hypnozoite and malarial relapse. Prog Clin Parasitol. 1989;1:1\u201319.","journal-title":"Prog Clin Parasitol"},{"key":"2868_CR4","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4269\/ajtmh.2006.75.402","volume":"75","author":"DR Hill","year":"2006","unstructured":"Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magil AJ. Primaquine: Report from CDC expert meeting on malaria chemoprophyxis I. Am Soc trop Med Hyg. 2006;75:402\u201315.","journal-title":"Am Soc trop Med Hyg"},{"key":"2868_CR5","unstructured":"World Health Organisation. WHO policy brief on single-dose primaquine as a gametocytocide in Plasmodium falciparum malaria. 2015. http:\/\/www.who.int\/malaria\/publications\/atoz\/policy-brief-single-dose-primaquine-pf\/en\/ . Accessed 3 Feb 2017."},{"key":"2868_CR6","unstructured":"Malaria Atlas Project. Modelled Plasmodium vivax relapse incidence in 2013 in Malaysia. http:\/\/www.map.ox.ac.uk\/browse-resources\/clinical-burden\/Pv_relapse\/MYS\/ . Accessed 6 July 2017."},{"key":"2868_CR7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-13-144","volume":"13","author":"KE Battle","year":"2014","unstructured":"Battle KE, Karhunen MS, Bhatt S, Gething PW, Howes RE, Golding N, et al. Geographical variation in plasmodium vivax relapse. Malar J. 2014;13:144.","journal-title":"Malar J"},{"key":"2868_CR8","unstructured":"Vector Borne Disease Sector, Disease Control Division, Ministry of Health. Malaria Situation in Malaysia. 2014."},{"key":"2868_CR9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1475-2875-10-297","volume":"10","author":"NJ White","year":"2011","unstructured":"White NJ. Determinants of relapse periodicity in plasmodium vivax malaria. Malar J. 2011;10:297.","journal-title":"Malar J"},{"key":"2868_CR10","unstructured":"Sim\u00f5es LR, Alves ER, Ribatski-Silva D, Gomes LT, Nery AF, Fontes CJF. Factors associated with recurrent plasmodium vivax malaria in Porto Velho, Rond\u00f4nia state, Brazil, 2009. Cad Saude. Publica 2014;30:1403\u201317."},{"key":"2868_CR11","unstructured":"World Health Organization. Guidelines for the treatment of malaria. 3rd ed. Geneva: WHO; 2015."},{"key":"2868_CR12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4269\/ajtmh.2007.76.203","volume":"76","author":"JL Goller","year":"2007","unstructured":"Goller JL, Jolley D, Ringwald P, Biggs B. Regional differences in the response of plasmodium vivax malaria to primaquine as anti-relapse therapy. Am J Trop Med Hyg. 2007;76:203\u20137.","journal-title":"Am J Trop Med Hyg."},{"key":"2868_CR13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1475-2875-11-214","volume":"11","author":"N Townell","year":"2012","unstructured":"Townell N, Looke D, McDougall D, McCarthy JS. Relapse of imported plasmodium vivax malaria is related to primaquine dose: a retrospective study. Malar J. 2012;11:214.","journal-title":"Malar J"},{"key":"2868_CR14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/1475-2875-10-355","volume":"10","author":"EA Pereira","year":"2011","unstructured":"Pereira EA, Ishikawa EAY, Fontes CJF. Adherence to plasmodium vivax malaria treatment in the Brazilian Amazon region. Malar J. 2011;10:355.","journal-title":"Malar J"},{"key":"2868_CR15","doi-asserted-by":"crossref","first-page":"28463","DOI":"10.18632\/oncotarget.4691","volume":"6","author":"T Li","year":"2015","unstructured":"Li T, Sheng J, Li W, Zhang X, Yu H, Chen X, et al. A new computational model for human thyroid cancer enhances the preoperative diagnostic efficacy. Oncotarget. 2015;6:28463\u201377.","journal-title":"Oncotarget"},{"key":"2868_CR16","first-page":"4","volume":"26","author":"G Chen","year":"2014","unstructured":"Chen G, Mao B, Pan Q, Liu Q, Xu X, Ning Y. Prediction rule for estimating advanced colorectal neoplasm risk in average-risk populations in southern Jiangsu Province. Chin J Cancer Res. 2014;26:4\u201311.","journal-title":"Chin J Cancer Res"},{"key":"2868_CR17","unstructured":"World Health Organization. WHO regional offices. Geneva: WHO; 2016. http:\/\/www.who.int\/about\/regions\/en\/ . Accessed 3 Feb 2017."},{"key":"2868_CR18","unstructured":"World Health Organization. WHO malaria terminology. Global Malaria Programme. Geneva: WHO; 2017. http:\/\/apps.who.int\/iris\/bitstream\/10665\/208815\/1\/WHO_HTM_GMP_2016.6_eng.ppd . Accessed 3 Feb 2017."},{"key":"2868_CR19","unstructured":"Vector Borne Disease Sector, Disease Control Division, Ministry of Health. Management Guideline of Malaria in Malaysia. 2014."},{"key":"2868_CR20","doi-asserted-by":"crossref","DOI":"10.1201\/b16343","volume-title":"Epidemiology: study design and data analysis","author":"M Woodward","year":"2013","unstructured":"Woodward M. Epidemiology: study design and data analysis. 3rd ed. Chapman and Hall: CRC Press; 2013.","edition":"3"},{"key":"2868_CR21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1600-0722.2004.00160.x","volume":"112","author":"T Y-K","year":"2004","unstructured":"Y-K T, Clerehugh V, Gilthorpe MS. Collinearity in linear regression is a serious problem in oral health research. Eur J Oral Sci. 2004;112:389\u201397.","journal-title":"Eur J Oral Sci"},{"key":"2868_CR22","doi-asserted-by":"crossref","unstructured":"Hosmer Jr DW, Lemeshow S. Assessing the fit of the model. In: Hosmer Jr DW, Lemeshow S, Sturdivant RX, editors. Applied Logistic Regression. 2nd ed. Wiley; 2000. p. 156\u201364.","DOI":"10.1002\/0471722146.ch5"},{"key":"2868_CR23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12028-014-0060-2","volume":"22","author":"D Asuzu","year":"2015","unstructured":"Asuzu D, Nystrom K, Amin H, Schindler J, Wira C, Greer D, et al. Comparison of 8 scores for predicting symptomatic intracerebral hemorrhage after IV yhrombolysis. Neurocrit Care. 2015;22:229\u201333.","journal-title":"Neurocrit Care"},{"key":"2868_CR24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4269\/ajtmh.2007.77.79","volume":"77","author":"RN Price","year":"2007","unstructured":"Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007;77:79\u201387.","journal-title":"Am J Trop Med Hyg"},{"key":"2868_CR25","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1371\/journal.pmed.0050128","volume":"5","author":"E Tjitra","year":"2008","unstructured":"Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, et al. Multidrug-resistant plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua. Indonesia PLoS Med. 2008;5:e128.","journal-title":"Indonesia PLoS Med"},{"key":"2868_CR26","unstructured":"WHO-CHOICE Study, Mean cost of health centre consultation cost for WPR B and SEAR B regions. http:\/\/www.who.int\/choice\/costs\/unit_costs\/en\/index.html . Accessed 30 June 2017."},{"key":"2868_CR27","doi-asserted-by":"crossref","unstructured":"White NJ, Imwong M. Relapse. Adv Parasitol. 2012. https:\/\/doi.org\/10.1016\/B978-0-12-397900-1.00002-5 .","DOI":"10.1016\/B978-0-12-397900-1.00002-5"},{"key":"2868_CR28","doi-asserted-by":"publisher","unstructured":"Galappaththy GNL, Tharyan P, Kirubakaran R. Primaquine for preventing relapse in people with plasmodium vivax malaria treated with chloroquine. Cochrane database of Syst Rev. 2013. doi: 10.1002\/14651858.CD004389.pub3.","DOI":"10.1002\/14651858.CD004389.pub3."},{"key":"2868_CR29","doi-asserted-by":"publisher","unstructured":"Douglas NM, Nosten F, Ashley EA, et al. Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Clin Infect Dis. 2011. doi: 10.1093\/cid\/ciq249 .","DOI":"10.1093\/cid\/ciq249"},{"key":"2868_CR30","doi-asserted-by":"publisher","unstructured":"Mueller I, Galinski MR, Tsuboi T, Arevalo-Herrera M, Collins WE, King CL. Natural acquisition of immunity to plasmodium vivax. Epidemiological observations and potential targets Adv Parasitol. 2013;81:77-131. doi: 10.1016\/B978-0-12-407826-0.00003-5 .","DOI":"10.1016\/B978-0-12-407826-0.00003-5"},{"key":"2868_CR31","doi-asserted-by":"publisher","unstructured":"Broderick C, Nadjm B, Smith V, Blaze M, Checkley A, Chiodini PL, et al. Clinical, geographical, and temporal risk factors associated with presentation and outcome of vivax malaria imported into the United Kingdom over 27 years: observational study. BMJ. 2015;350:h1703. doi: 10.1136\/bmj.h1703 .","DOI":"10.1136\/bmj.h1703"},{"key":"2868_CR32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1645\/0022-3395(2002)088[0521:PVBSD]2.0.CO;2","volume":"88","author":"FE Mckenzie","year":"2002","unstructured":"Mckenzie FE, Jeffery GM, Collins WE. Plasmodium vivax blood-stage dynamics. J Parasitol. 2002;88:521\u201335.","journal-title":"J Parasitol"},{"key":"2868_CR33","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/cid\/ciw121","volume":"62","author":"MJ Grigg","year":"2016","unstructured":"Grigg MJ, William T, Menon J, Barber BE, Wilkes CS, Rajahram GS, et al. Efficacy of artesunate-mefloquine for chloroquine-resistant Plasmodium vivax malaria in Malaysia: an open-label, randomized, controlled trial. Clin Infect Dis. 2016;62:1403\u201311.","journal-title":"Clin Infect Dis"},{"key":"2868_CR34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/CMR.00025-08","volume":"22","author":"DL Doolan","year":"2009","unstructured":"Doolan DL, Dobano C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev. 2009;22:13\u201336.","journal-title":"Clin Microbiol Rev"},{"key":"2868_CR35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2229-5070.175081","volume":"6","author":"HA Antony","year":"2016","unstructured":"Antony HA, Parija SC. Antimalarial drug resistance: an overview. Trop Parasitol. 2016;6:30\u201341.","journal-title":"Trop Parasitol"},{"key":"2868_CR36","doi-asserted-by":"publisher","first-page":"e82553","DOI":"10.1371\/journal.pone.0082553","volume":"8","author":"NR Abdullah","year":"2013","unstructured":"Abdullah NR, Barber BE, William T, Norahmad NA, Satsu UR, Muniandy PK, et al. Plasmodium vivax population structure and transmission dynamics in Sabah Malaysia. PLoS One. 2013;8:e82553. doi: 10.1371\/journal.pone.0082553 .","journal-title":"PLoS One."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2868-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T13:43:20Z","timestamp":1570455800000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2868-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2868"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2868-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"759"}}